Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 1999

View Archived Issues

Atugen and Roche Bioscience enter target validation collaboration

Radicicol derivative depletes Hsp90-associated molecules, exhibits antitumor activity

King Pharmaceuticals to acquire Lorabid from Lilly

GAD65 peptides prevent diabetes in mouse model

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

ROCK inhibitor Y-27632 affects ET-1-induced hypertrophy in rat cardiac myocytes

Ivax completes tender offer for outstanding shares of Galena

Genelabs Technologies: Q2 1999 highlights

Patent for wound healing technology patent awarded to BioSpecifics and Tufts

Merck launches COX-2 inhibitor in the U.K.

Corixa highlights collaborative agreements established in Q2 1999

Cangene to acquire Hyal

Promising troponin I analogue identified

Phase I trial begins for SMART 1D10 antibody in non-Hodgkin's B-cell lymphoma

First launch for bile acid-sequestering agent colestimide

Guilford and Amgen begin clinical testing of neuroimmunophilins

PDGFr-TK inhibitor prevents restenosis following angioplasty in minipigs

Diatide receives second major product approval in less than 12 months

NIH researchers identify potential clue to the prevention of prion diseases

U.K.'s MCA is first to approve Synercid for marketing

Indian academic team identifies interesting new antibacterial compounds

Novel AMPA/NMDA antagonists discovered at Rhone-Poulenc Rorer

INSERM describes TPP II inhibitors and their use in treating eating disorders, obesity

SB team identifies bone resorption inhibitors selective for mammalian osteoclasts

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...